Sign up Australia
Proactive Investors - Run By Investors For Investors

Eve Investments targets US$40 billion medical nutrition market as Meluka Honey gains traction

Annual honey production of 100 tonnes per year is being targeted within the next 12 months.
Honey jars
The initial supply of Meluka Honey to the US will be through Naturally Australian Products

Eve Investments (ASX:EVE) received support today after the company updated the market regarding its investments in Meluka Health and Omni Medical Nutrition.

The company is targeting the broader global medical nutrition market which was estimated in 2017 to have a value of US$37.6 billion, increasing to US$52.3 billion by 2022.

Omni has established distribution and sales agreements in relation to its pre-meal drinks for diabetes.

Eagle Health heavily invested in project

This has been facilitated through an agreement with Eagle Health Holdings (ASX:EHH), which has invested $3.1 million and committed a further $5.7 million for factory, warehouse and exhibition centre upgrades.

This agreement includes an upfront licensing fee of $1.5 million payable to Omni with $1 million paid on completion of the licence agreement.

A further US$500,000 will be paid when registration of the pre-meal drink as a medical food is achieved through the China Food and Drug Administration authority.

Shares are up 20% to 1.2 cents in mid-afternoon trade on volume of more than 9.4 million.

Meluka provides exposure to honey market

Eve completed its 50% investment in Meluka Health in late 2017.

Meluka Honey is a wholly-owned subsidiary and the investment has also provided a stake in essential oil producer, Eco Botanicals.

Annual honey production of 100 tonnes per year is being targeted within the next 12 months.

The initial supply of Meluka Honey to the US market will be through a distribution agreement with Naturally Australian Products.

View full EVE profile View Profile

Eve Investments Ltd Timeline

Related Articles

maps of Australia with company projects marked
April 18 2018
Samples from the Mt Read Cobalt Project graded up to 7,800 ppm cobalt.
Picture of territory at Piedmont Lithium Project
April 30 2018
The company has acquired 630 acres in four separate transactions between September 2017 and March 2018.
Cobalt sample on the periodic table
May 23 2018
One of Australia’s few potential cobalt producers from sulphide-based deposits, where cobalt production is underpinned by copper and gold.

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use